Trever G Bivona
26PUBLICATIONS
251CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (26)
Sort by Publication Date:
|Mar 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.Daniel E Gracilla, Shruti Menon, Marcus R Breese
|Feb 07, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Nov 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Nov 18, 2025
Temporal photoproximity labeling of ligand-activated EGFR neighborhoods using MultiMap.Zhi Lin, Wayne Ngo, Yu-Ting Chou
|Jun 03, 2025
Acquired resistance in cancer: towards targeted therapeutic strategies.Alice Soragni, Erik S Knudsen, Thomas N O'Connor
|Mar 07, 2025
Condensates as a Culprit in RAS Activation and Inhibitor Resistance.Hannah C Bergo, Logan B Leak, Trever G Bivona
Pageof 5
Frequent Collaborators
8 joint publications
Collin M Blakely
8 joint publications
Wei Wu
7 joint publications
D Lucas Kerr
5 joint publications
Jack A Roth
4 joint publications
Shigeki Nanjo
3 joint publications
Tadashi Manabe
3 joint publications
Natalie Vokes
3 joint publications
Jonathan Weissman
3 joint publications
Ismail M Meraz
2 joint publications
Nicole Zhang
